Antiangiogenic therapy in acute myelogenous leukemia: targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies.

Hatfield, Kimberley J

Antiangiogenic therapy in acute myelogenous leukemia: targeting of vascular endothelial growth factor and interleukin 8 as possible antileukemic strategies. [electronic resource] - Current cancer drug targets Jun 2005 - 229-48 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1568-0096

10.2174/1568009054064651 doi


Angiogenesis Inhibitors--physiology
Animals
Antineoplastic Agents--therapeutic use
Humans
Interleukin-8--metabolism
Leukemia, Myeloid, Acute--drug therapy
Vascular Endothelial Growth Factor A--drug effects